Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Perspectives
Open Access

Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19

Meagan L. Adamsick, Ronak G. Gandhi, Monique R. Bidell, Ramy H. Elshaboury, Roby P. Bhattacharyya, Arthur Y. Kim, Sagar Nigwekar, Eugene P. Rhee and Meghan E. Sise
JASN July 2020, 31 (7) 1384-1386; DOI: https://doi.org/10.1681/ASN.2020050589
Meagan L. Adamsick
1Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronak G. Gandhi
1Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monique R. Bidell
1Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramy H. Elshaboury
1Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roby P. Bhattacharyya
2Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Roby P. Bhattacharyya
Arthur Y. Kim
2Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sagar Nigwekar
3Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sagar Nigwekar
Eugene P. Rhee
3Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghan E. Sise
3Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 31 no. 7 1384-1386
DOI 
https://doi.org/10.1681/ASN.2020050589
PubMed 
32513665

Published By 
American Society of Nephrology
Print ISSN 
1046-6673
Online ISSN 
1533-3450
History 
  • Published online June 30, 2020.

Article Versions

  • Earlier version (June 8, 2020 - 05:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2020 by the American Society of Nephrology

Author Information

  1. Meagan L. Adamsick1,
  2. Ronak G. Gandhi1,
  3. Monique R. Bidell1,
  4. Ramy H. Elshaboury1,
  5. Roby P. Bhattacharyya2,
  6. Arthur Y. Kim2,
  7. Sagar Nigwekar3,
  8. Eugene P. Rhee3 and
  9. Meghan E. Sise3
  1. 1Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts
  2. 2Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
  3. 3Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
  1. Correspondence:
    Dr. Meghan E. Sise, Division of Nephrology, Department of Medicine, Massachusetts General Hospital, 165 Cambridge Street, Suite 302, Boston, MA 02114. Email: msise{at}partners.org

Funding

  • National Institute of Diabetes and Digestive and Kidney Diseases

    DK117014

Statistics from Altmetric.com

Article usage

Article usage: June 2020 to January 2021

AbstractFullPdf
Jun 2020077591832
Jul 2020081041868
Aug 2020058421360
Sep 2020055411079
Oct 2020065861223
Nov 2020065201591
Dec 2020064101328
Jan 2021053721150

Cited By...

  • 17 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 31 (7)
Journal of the American Society of Nephrology
Vol. 31, Issue 7
July 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
Meagan L. Adamsick, Ronak G. Gandhi, Monique R. Bidell, Ramy H. Elshaboury, Roby P. Bhattacharyya, Arthur Y. Kim, Sagar Nigwekar, Eugene P. Rhee, Meghan E. Sise
JASN Jul 2020, 31 (7) 1384-1386; DOI: 10.1681/ASN.2020050589

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
Meagan L. Adamsick, Ronak G. Gandhi, Monique R. Bidell, Ramy H. Elshaboury, Roby P. Bhattacharyya, Arthur Y. Kim, Sagar Nigwekar, Eugene P. Rhee, Meghan E. Sise
JASN Jul 2020, 31 (7) 1384-1386; DOI: 10.1681/ASN.2020050589
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Remdesivir
    • Risks of Remdesivir
    • Risk of SBECD Carrier Accumulation
    • Disclosures
    • Funding
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Separate and Unequal: Race-Based Algorithms and Implications for Nephrology
  • COVID-19 and Dialysis Patients: Unsolved Problems in Early 2021
  • Ensuring the Equitable Advancement of American Kidney Health—the Need to Account for Socioeconomic Disparities in the ESRD Treatment Choices Model
Show more Perspectives

Cited By...

  • New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
  • Management of COVID-19 in special populations with kidney disease
  • Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis
  • Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
  • Google Scholar

Similar Articles

Related Articles

  • Remdesivir in COVID-19 Patients with Impaired Renal Function
  • Authors’ Reply
  • PubMed
  • Google Scholar

Keywords

  • acute renal failure
  • end-stage renal disease
  • antiviral
  • COVID-19

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire